
NEWS
Yaohai’s CRDMO is the New Trend
Yaohai Bio-Pharma has once again been recognized as a leading innovator in the global biopharmaceutical industry. During the 2026 Future Healthcare 100 Conference held on

Yaohai Bio-Pharma has once again been recognized as a leading innovator in the global biopharmaceutical industry. During the 2026 Future Healthcare 100 Conference held on

Yaohai Bio-Pharma will participate in Swiss Biotech Day 2026, one of Europe’s most influential biotechnology events. The conference will take place on May 4–5, 2026,

Yaohai Bio-Pharma provides integrated, end-to-end microbial fermentation services under the highest global GMP standards. With this combination of technology and experience, we become a reliable

Yaohai Bio-Pharma has more than 15 years of experience in microbial cell line development and cell bank construction. Microbial cell line development and high-yield strain
